Alger Life Sciences Innovation Fund LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Apr 10, 2026, the fund has sold $30,286,264 of interests to 13 investors since its first sale in May 2022. The minimum investment it accepts from an outside investor is $500,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Daniel Chung; Alger Alternative Holdings II, LLC; Hal Liebes.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $30,286,264Cumulative sales reported on Form D
- Investors
- 13
- First sale
- May 20, 2022
- Minimum investment
- $500,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Daniel Chung; Alger Alternative Holdings II, LLC; Hal Liebes
- Latest Form D
- Apr 10, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 10, 2026 | Form D/A (amendment) | $30,286,264 | 13 | SEC.gov ↗ |
| Apr 11, 2025 | Form D/A (amendment) | $17,311,618 | 19 | SEC.gov ↗ |
| Apr 12, 2024 | Form D/A (amendment) | $23,718,260 | 19 | SEC.gov ↗ |
| Apr 12, 2023 | Form D/A (amendment) | $12,217,947 | 13 | SEC.gov ↗ |
| Apr 18, 2022 | Form D | $0 | 0 | SEC.gov ↗ |
5 Form D filings in the SEC's electronic records (2008 onward), the earliest on Apr 18, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Vehicles of this fund (2)
| Legal name on Form D | SEC CIK | Location reported | Total raised | Investors | Minimum | Latest Form D |
|---|---|---|---|---|---|---|
| Alger Life Sciences Innovation Fund LP (main vehicle on this page) | 1923614 | New York, New York | $30,286,264 | 13 | $500,000 | Apr 10, 2026 |
| Alger Life Sciences Innovation Offshore Fund, LP | 2005494 | New York, New York | $7,297,443 | 8 | $500,000 | Apr 10, 2026 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of Alger Life Sciences Innovation Fund LP, the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.
Raise history: Alger Life Sciences Innovation Offshore Fund, LP
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 10, 2026 | Form D/A (amendment) | $7,297,443 | 8 | SEC.gov ↗ |
| Apr 11, 2025 | Form D/A (amendment) | $4,395,902 | 8 | SEC.gov ↗ |
| Apr 12, 2024 | Form D/A (amendment) | $3,096,960 | 5 | SEC.gov ↗ |
| Jan 3, 2024 | Form D | $0 | 0 | SEC.gov ↗ |
4 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jan 3, 2024. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Alger Life Sciences Innovation Fund LP
What is the minimum investment for Alger Life Sciences Innovation Fund LP?
According to its latest Form D, filed Apr 10, 2026, the minimum investment Alger Life Sciences Innovation Fund LP accepts from an outside investor is $500,000.
Who can invest in Alger Life Sciences Innovation Fund LP?
Alger Life Sciences Innovation Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Alger Life Sciences Innovation Fund LP raised?
Alger Life Sciences Innovation Fund LP reports $30,286,264 sold from 13 investors on its Form D filed Apr 10, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Alger Life Sciences Innovation Fund LP based?
Alger Life Sciences Innovation Fund LP is based in New York, New York.
When did Alger Life Sciences Innovation Fund LP launch?
Alger Life Sciences Innovation Fund LP reports its first sale in May 2022, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 36% of the 2,526 hedge funds based in New York, and more than 37% of all 10,153 that report sales.